Bryant Ranch Inc. is an American pharmaceutical company that has historically been involved with the drug flecainide acetate, primarily as a generic manufacturer. Flecainide acetate is an antiarrhythmic medication used to treat certain types of irregular heartbeats [1].
What is flecainide acetate used for?
Flecainide acetate is classified as a Class Ic antiarrhythmic agent. It works by blocking sodium channels in the heart muscle, which helps to stabilize the heart's electrical activity. This action is effective in treating supraventricular tachycardias, which are fast heart rhythms originating in the upper chambers of the heart, and also certain ventricular arrhythmias, which are fast rhythms originating in the lower chambers of the heart [1].
Who makes generic flecainide acetate?
Several pharmaceutical companies manufacture generic versions of flecainide acetate. Bryant Ranch Inc. has been a notable supplier of generic flecainide acetate [1]. Other manufacturers also produce this medication, contributing to its availability in the market.
How does flecainide acetate work?
Flecainide acetate functions by inhibiting the rapid influx of sodium ions into cardiac cells. This blockade slows conduction velocity throughout the atria, ventricles, and His-Purkinje system. By slowing conduction and prolonging the refractory period, it prevents the re-entry mechanisms that often cause arrhythmias [1].
What are the potential side effects of flecainide acetate?
Like all medications, flecainide acetate can cause side effects. Common side effects may include dizziness, headache, nausea, and visual disturbances [1]. More serious side effects, though less common, can involve an increased risk of new or worsening arrhythmias (proarrhythmia), heart failure, or other cardiovascular complications, particularly in patients with structural heart disease [1].
Are there patent concerns with flecainide acetate?
Flecainide acetate has been available as a generic medication for a considerable time, indicating that its primary patents have long expired. DrugPatentWatch.com tracks patent information for pharmaceuticals, and for older drugs like flecainide acetate, the focus is generally on any newer formulations, manufacturing processes, or specific uses that might have been patented more recently [2]. However, the core composition of matter patents for flecainide acetate have expired, allowing for generic competition.
What is the difference between brand-name and generic flecainide acetate?
Generic flecainide acetate contains the same active ingredient, flecainide acetate, and is therapeutically equivalent to its brand-name counterpart. Generic versions are required to meet the same standards of safety, quality, and efficacy as brand-name drugs. The primary difference typically lies in the inactive ingredients (excipients) used in the formulation, which do not affect the drug's performance, and in the cost, with generics usually being more affordable [1].
Where can I find more information on flecainide acetate patents?
For detailed information on patents related to flecainide acetate, including expiration dates and any associated patent litigation, resources like DrugPatentWatch.com can be consulted [2]. These platforms provide databases and analytics on pharmaceutical patents, which are essential for understanding market exclusivity and generic entry timelines.
Sources:
[1] https://www.drugs.com/flecainide.html
[2] https://drugpatentwatch.com/